NEU 2.18% $20.66 neuren pharmaceuticals limited

Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-153

  1. 870 Posts.
    lightbulb Created with Sketch. 243
    Happy to be proven wrong put I didn't hear him say they wouldn't need to undertake P2 trials in future. I understood him to say that future P2 trials could be simplified and speeded up by removing some of the current safety protocols if the FDA accepted that the molecule was safe.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.66
Change
0.440(2.18%)
Mkt cap ! $2.671B
Open High Low Value Volume
$20.45 $21.10 $20.39 $4.292M 206.5K

Buyers (Bids)

No. Vol. Price($)
4 129 $20.65
 

Sellers (Offers)

Price($) Vol. No.
$20.67 102 5
View Market Depth
Last trade - 13.03pm 26/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.